PHG News & Events

Royal Philips announced it has received U.S. Food and Drug Administration 510(k) clearance for the Philips Spectral CT Verida system. "With FDA clearance for Verida, we are bringing the next evolution of spectral CT to more markets," said Dan Xu, Business Leader of CT at Philips. "By combining always-on spectral imaging with AI-powered reconstruction, Verida enables clinicians to see more, first time right, supporting faster, more informed decisions and expanding the role of CT across clinical pathways."

Philips announced it has received FDA 510(k) clearance for EchoNavigator R5.0 with DeviceGuide, an AI-powered software solution that assists physicians during one of interventional cardiology's most technically demanding procedures - repairing leaking mitral valves through a minimally invasive approach.

Philips has announced the launch of its interventional guidance platform, IntraSight Plus, which is cleared for clinical use in the USA and Europe. With CE marking and FDA 510 clearance, the redesigned platform combines diagnostic and treatment planning tools. By streamlining access to interventional tools, IntraSight Plus enables clinicians to diagnosis, virtually plan treatment, guide device placement and verify results all on a single screen.